Owner Rhode Island Hospital, A Lifespan Partner Panacea Pharmaceuticals, Inc.

Inventors Ghanbari, Hossein A.; Deutch, Alan H.; Wands, Jack R.; De La Monte, Suzanne M.

Agent Cullen & Co

Pub. Number AU-A-2009200228

Parent 2002303802

Filing date 21 January 2009

Wipo publication date 12 February 2009

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

A61K 39/395 (1970.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61K 49/16 (2006.01) Preparations for testing

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C12N 9/06 (2006.01) Enzymes, e.g. ligases (6.) - acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer